Late Breaking GI Updates

posted Dec 12 2007
We would like to thank Drs Scott Berry, Chris Booth, & Phil Bedard for providing us with the latest GI updates

The publication of the National Cancer Institute Clinical Trials Group - CO.17 trial in the New England Journal of Medicine in November capped off a year of new data for the use of EGFR inhibitors for the treatment of metastatic colorectal cancer. Dr. Philippe Bedard has compiled and synthesized the available information in this excellent slide kit.

Defining the Role of EGFR Monoclonal Antibody Therapy in Metastatic Colorectal Cancer - by Dr Phil Bedard

Gemcitabine Plus Capecitabine Compared With Gemcitabine Alone in Advanced Pancreatic Cancer: A Randomized, Multicenter, Phase III Trial - by Dr Chris Booth